BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32104540)

  • 1. The Role of Reactive Oxygen Species and Nitric Oxide in the Inhibition of
    Huang M; Huang H; Lv W; Xiao H; Gao Y; Tang H
    Oxid Med Cell Longev; 2020; 2020():8548619. PubMed ID: 32104540
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of
    Huang H; Huang M; Lv W; Hu Y; Wang R; Zheng X; Ma Y; Chen C; Tang H
    Front Pharmacol; 2019; 10():1143. PubMed ID: 31632277
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of NADPH Oxidase in the Inhibition of
    Huang H; Lv W; Chen Y; Zheng X; Hu Y; Wang R; Huang M; Tang H
    Front Microbiol; 2017; 8():2636. PubMed ID: 29375505
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of inhibition of nitric oxide synthase on Pseudomonas aeruginosa infection of respiratory mucosa in vitro.
    Dowling RB; Newton R; Robichaud A; Cole PJ; Barnes PJ; Wilson R
    Am J Respir Cell Mol Biol; 1998 Dec; 19(6):950-8. PubMed ID: 9843930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase inhibitors decrease human polymorphonuclear leukocyte luminol-dependent chemiluminescence.
    Catz SD; Carreras MC; Poderoso JJ
    Free Radic Biol Med; 1995 Dec; 19(6):741-8. PubMed ID: 8582646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
    Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
    Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthases.
    Kittel A; Maas R
    Curr Pharm Des; 2014; 20(22):3530-47. PubMed ID: 24180385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.
    Leiper J; Vallance P
    Cardiovasc Res; 1999 Aug; 43(3):542-8. PubMed ID: 10690326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase inhibitors and cerebral vasospasm.
    Jung CS
    Acta Neurochir Suppl; 2011; 110(Pt 1):87-91. PubMed ID: 21116921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine impairs glucose utilization via ROS/TLR4 pathway in adipocytes: an effect prevented by vitamin E.
    Yang ZC; Wang KS; Wu Y; Zou XQ; Xiang YY; Chen XP; Li YJ
    Cell Physiol Biochem; 2009; 24(1-2):115-24. PubMed ID: 19590199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulus-specific blockade of nitric oxide-mediated dilatation by asymmetric dimethylarginine (ADMA) and monomethylarginine (L-NMMA) in rat aorta and carotid artery.
    Al-Zobaidy MJ; Craig J; Brown K; Pettifor G; Martin W
    Eur J Pharmacol; 2011 Dec; 673(1-3):78-84. PubMed ID: 22056836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase.
    Miesel R; Kurpisz M; Kroger H
    Free Radic Biol Med; 1996; 20(1):75-81. PubMed ID: 8903681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
    Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of osteoblast growth by nitric oxide synthase inhibitors: an effect independent of nitric oxide and arginine transport inhibition.
    Riancho JA; Zarrabeitia MT; Salas E; González-Macías J
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):663-7. PubMed ID: 9121222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic inhibition of Trichophyton rubrum: in vitro activity and the role of oxidative and nitrosative bursts in fungal death.
    Baltazar Lde M; Soares BM; Carneiro HC; Avila TV; Gouveia LF; Souza DG; Ferreira MV; Pinotti M; Santos Dde A; Cisalpino PS
    J Antimicrob Chemother; 2013 Feb; 68(2):354-61. PubMed ID: 23134678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of endogenous nitric oxide synthase inhibitors and endothelin-1 for regulating myometrial contractions during gestation in the rat.
    Momohara Y; Sakamoto S; Obayashi S; Aso T; Goto M; Azuma H
    Mol Hum Reprod; 2004 Jul; 10(7):505-12. PubMed ID: 15155819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ability of asymmetric dimethylarginine (ADMA) or monomethylarginine (L-NMMA) to block endothelium-dependent, nitric oxide-mediated relaxation in rat aorta is inversely related to the efficacy of the relaxant stimulus.
    Al-Zobaidy MJ; Martin W
    Eur J Pharmacol; 2014 Oct; 741():171-7. PubMed ID: 25149663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
    Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
    Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.